- Home
- RVPH vs XBP Comparison
RVPH vs XBP Comparison
Compare RVPH & XBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- XBP
- Stock Information
- Founded
- RVPH 2006
- XBP 2020
- Country
- RVPH United States
- XBP United States
- Employees
- RVPH N/A
- XBP N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- XBP Business Services
- Sector
- RVPH Health Care
- XBP Consumer Discretionary
- Exchange
- RVPH Nasdaq
- XBP Nasdaq
- Market Cap
- RVPH 30.1M
- XBP 71.0M
- IPO Year
- RVPH N/A
- XBP N/A
- Fundamental
- Price
- RVPH $0.40
- XBP $1.00
- Analyst Decision
- RVPH Strong Buy
- XBP
- Analyst Count
- RVPH 5
- XBP 0
- Target Price
- RVPH $5.20
- XBP N/A
- AVG Volume (30 Days)
- RVPH 1.3M
- XBP 392.1K
- Earning Date
- RVPH 11-13-2025
- XBP 11-11-2025
- Dividend Yield
- RVPH N/A
- XBP N/A
- EPS Growth
- RVPH N/A
- XBP N/A
- EPS
- RVPH N/A
- XBP N/A
- Revenue
- RVPH N/A
- XBP $148,332,000.00
- Revenue This Year
- RVPH N/A
- XBP N/A
- Revenue Next Year
- RVPH N/A
- XBP N/A
- P/E Ratio
- RVPH N/A
- XBP N/A
- Revenue Growth
- RVPH N/A
- XBP 0.23
- 52 Week Low
- RVPH $0.30
- XBP $0.42
- 52 Week High
- RVPH $4.28
- XBP $2.56
- Technical
- Relative Strength Index (RSI)
- RVPH 34.75
- XBP 67.74
- Support Level
- RVPH $0.50
- XBP $0.80
- Resistance Level
- RVPH $0.47
- XBP $1.04
- Average True Range (ATR)
- RVPH 0.03
- XBP 0.10
- MACD
- RVPH -0.01
- XBP 0.05
- Stochastic Oscillator
- RVPH 14.30
- XBP 91.34
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About XBP XBP Europe Holdings Inc.
XBP Global Holdings Inc is a multinational leader in business process automation, serving over 2,500 clients-including more than 30 Fortune 100 companies. Its proprietary software and deep domain expertise position it as a trusted technology and services partner. With cloud-based solutions and a global footprint, XBP Global delivers measurable value, improves advances digital transformation, improves market-wide liquidity by expediting payments, and promotes sustainable business practices.